Business Daily Media

Men's Weekly

.

LiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis Media

HANOI, VIETNAM - Media OutReach Newswire - 19 May 2025 - LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking international scientific journal Scientific Reports-Nature, recognizing its effectiveness in supporting the treatment of rhinosinusitis and otitis media in children.

This marks the third consecutive study on the product published in a prestigious international scientific platform, reinforcing a promising new direction in non-antibiotic respiratory care.

Photo (3)

The findings from the clinical study, conducted Thai Binh University of Medicine and Pharmacy in collaboration with other institutions, was published on January 27, 2025, in Scientific Reports-Nature, a renowned journal under the Nature Portfolio (UK). The results demonstrated significant effectiveness in children within just 3–7 days of use. Additionally, data also showed positive improvements in adults, highlighting the product's potential for broader application in the future.

The study was carried out from November 2023 to December 2024 with the participation of 126 patients, including both children and adults. Among children with acute rhinosinusitis and perforated acute otitis media, the treatment results were particularly notable: after 3 days of using LiveSpo® NAVAX, nasal congestion decreased by 68%, twice as much as the saline group. After 7 days, 97% of the children had no more nasal discharge, and 100% had no more ear discharge. The concentration of pathogenic bacteria Streptococcus pneumoniae in nasal and ear secretions dropped more than 1,200 times. Importantly, no side effects were recorded during the entire trial – even in children with weakened immune systems.

In the adult group with acute sinusitis, symptoms such as nasal congestion, facial pain, and purulent discharge improved significantly after 3 days of use – with reductions of 53%, 78%, and 61%, respectively. After 7 days, 91% of patients no longer experienced nasal discharge. Laboratory results showed a substantial reduction in pathogenic bacteria: Streptococcus pneumoniae decreased over 380-fold and Haemophilus influenzae decreased over 49,000-fold compared to the Control group receiving physiological saline

According to the research team, the effectiveness of LiveSpo® NAVAX origins from its ability to modulate local inflammatory responses and enhance mucosal immunity through the competitive biological mechanism of spore-forming Bacillus probiotics. Inflammatory markers such as IL-6, IL-8, and TNF-α significantly decreased, while levels of IgA – a key protective antibody at the mucosal surface – increased, contributing to the restoration of the nose and ear's natural defense barrier.

This study not only adds to the growing body of scientific evidence supporting LiveSpo® NAVAX's efficacy in respiratory care but also affirms Vietnam's biomedical research capabilities on the international scientific map. It paves the way for a safe, sustainable respiratory treatment alternative that reduces reliance on antibiotics – especially for vulnerable groups like children.

Dr. Nguyen Hoa Anh, Chairman and Founder of LiveSpo Pharma, shared:
"At LiveSpo, we prioritize the research and development of internationally standardized products, combining modern medicine with advanced probiotic technology to deliver safe and effective health solutions for the community – all with a vision of A Future Without Antibiotics."

References:
Khieu TH, Le DP, Nguyen BT, Ngo BT, Chu HT, Truong DM, Nguyen HM, Nguyen AH, Pham TD, Van Nguyen AT. Alleviating symptoms of paediatric acute rhinosinusitis and acute otitis media with otorrhea using nasal-spraying Bacillus probiotics: a randomized controlled trial. Sci Rep. 2025 Jan 27;15(1):3410. doi: 10.1038/s41598-025-87372-2. PMID: 39870748; PMCID: PMC11772584.
Hashtag: #LiveSpo


The issuer is solely responsible for the content of this announcement.

About LiveSpo Pharma

LiveSpo is an R&D, manufacturing, and distribution brand of Clinically Proven Medical Probiotics, leading in breakthrough technology, rapid effectiveness, and convenience, aiming for "A Future Without Antibiotics".

Our vision: In 2027, LiveSpo will have 1.5 million consumers who use Spore probiotics for digestive and respiratory health instead of antibiotics, with outstanding benefits and customer experiences. Established since 2010 by Dr. Nguyen Hoa Anh (Dr. ANH) and his colleagues, LiveSpo has remained steadfast in its belief that Live Probiotic Spores - Spobiotic - will pave the way to a future without antibiotics for everyone.

Hotline: 1800.088808

Website:

News from Asia

Studio City Extends Toy Story Campaign with Splashing Summer Fun at Studio City Water Park

MACAU SAR - Media OutReach Newswire – 18 July 2025 - Studio City is excited to announce the extension of its popular Toy Story campaign, now making a big splash at Studio City Water Park...

Trend Micro Celebrates 20th Consecutive Recognition as a Leader in Gartner® Magic Quadrant™ Endpoint Protection Platforms

Threat intelligence and security capabilities continue to outpace threats HONG KONG SAR - Media OutReach Newswire - 18 July 2025 – Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybers...

F88 earns Gold Level Certification for Client Protection

HANOI, VIETNAM - Media OutReach Newswire - 18 July 2025 - F88, a pioneer in Việt Nam's alternative finance sector, has once again affirmed its leadership position by being awarded the Gold Level C...

SKINARMA’s JAGER collection redefines street-smart carry with raw utility and urban edge

SINGAPORE - Media OutReach Newswire - 21 July 2025 - SKINARMA has launched the JAGER collection, a versatile lineup built for everyday explorers who need gear that keeps up with their pace...

Counterfeit and Refurbished Transducers Pose Serious Safety Risks

Merz Aesthetics® Hong Kong Launches Ultherapy® Authenticity Verification Reward Program This August Consumers Urged to Verify Ultherapy® Transducers Authenticity for Safe and Effective Treatments H...

IVD Medical Holding Limited (01931.HK): Officially launched the application for the US stablecoin license and accelerated the landing of the IVDNewCo Exchange ecosystem

HONG KONG SAR - Media OutReach Newswire - 21 July 2025 – IVD Medical Holding Limited(01931.HK) - Forward-looking layout of the historical opportunity of the US "Genius Act", the IVDD stablecoin pl...

FaatGo Officially Launches: A Hong Kong-Based Legal Platform Specializing in Criminal Defence and Injury Compensation

HONG KONG SAR - Media OutReach Newswire - 21 July 2025 - In response to the increasing demand for accessible and trustworthy legal information, FaatGo (https://faatgo.com/) has officially launche...

Galaxy Macau Ushers in ‘A Summer More Colorful’

The Award-Winning Integrated Resort Unveils a Dazzling Summer of Unparalleled Fun and Exclusive Rewards MACAU SAR - Media OutReach Newswire – 21 July 2025 - As the summer sun shines brightly, Gala...

Southeast Asia’s First Smart Battery Swapping Station Officially Launched: U Power Accelerates EV Ecosystem Across Three Continents

Hong Kong’s first station leads East Asia; Portugal and Peru mark U Power’s entry into Europe and South America PHUKET, THAILAND - EQS Newswire - 21 July 2025 - U Power Limited (Nasdaq: UCAR) and U...

V-Green introduces EV charging station partnership opportunities in the Philippines: Stable Revenue – Zero Risk – Breakthrough Potential

MANILA, PHILIPPINES - Media OutReach Newswire - 21 July 2025 - As Southeast Asia's electric vehicle (EV) market enters a phase of rapid expansion, V-Green Global Charging Station Development JSC a...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Australian Businesses Still Stuck in the AI Hype Cycle

Data Governance Failures, ROI Gaps and Unclear Strategy Slowing Progress Despite artificial intelligence (AI) dominating headlines and boardroom ag...

How to ensure your manufacturing business survives international tariff turmoil

Optimising your operations in FY2026 will help you combat the challenges of a volatile trading environment. Up, down, in out…Since the commence...

Why Apptio is Enhancing Visibility into AI and Hybrid Cloud

AI investments have become a strategic priority for business with the mindset that if you're not using AI, you're falling behind. But according to...

Beyond borders: Building a scalable strategy for international hiring

For many Australian businesses, growth increasingly depends on thinking beyond local borders.  As wage pressures rise, and specialised talent pool...

Sell by LayBy